FDA Adverse Event Injury Summary report: N

O-ARM IMAGING SYSTEM

MDR report key: 22751527 · Received August 8, 2025

Report

Report Number
3004785967-2025-00546
Event Type
Injury
Date Received
August 8, 2025
Date of Event
January 22, 2024
Report Date
August 8, 2025
Manufacturer
MEDTRONIC NAVIGATION, INC. (BOXBOROUGH)
Product Code
OXO
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

E0506: BLEEDING E2336: HYPOVOLEMIC CHOC F1205: TRANSIENT IMPACT F1910: PROCEDURE ABORTED G2: THIS EVENT OCCURRED IN (B)(6), SEE SECTION E. H3, H6: NO PRODUCTS WERE RETURNED TO MEDTRONIC FOR ANALYSIS. CODES B17, C20, AND D15 ARE APPLICABLE. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

CITATION: EUROPEAN SPINE JOURNAL (2024) 33:1930¿1940 HTTPS://DOI.ORG/10.1007/S00586-023-08121-5 SUMMARY: PURPOSE: TO DESCRIBE THE TECHNIQUE AND REVIEW THE ONCOLOGICAL AND SURGICAL RESULTS OF THE EN BLOC RESECTION ASSISTED BY RETROPERITONEAL LAPAROSCOPY IN A SINGLE PRONE POSITION FOR TUMORS IN THE THORACOLUMBAR REGION. METHODS: MONOCENTRIC RETROSPECTIVE CASE STUDY. PROCEDURE WAS PERFORMED IN A SINGLE PRONE POSITION BY A DUAL TEAM OF SPINE AND THORACOVASCULAR SURGEONS. AN ENDOSCOPIC BALLOON WAS INFLATED IN THE RIGHT RETROPERITONEAL CAVITY. A PLAN WAS DEVELOPED BETWEEN THE ANTERIOR SPINE AND VENA CAVA AS WELL AS ABDOMINAL AORTA WITH SEGMENTAL VESSELS LIGATION. STRUCTURES AT RISK WERE SAFELY PROTECTED UNDER ENDOSCOPY DURING HORIZONTAL OR SAGITTAL OSTEOTOMIES. RESULTS: FROM 2021, SEVEN PATIENTS AGED A MEDIAN 52-YEAR-OLD (RANGE, 34¿67) WERE INCLUDED. INVOLVED SPINAL SEGMENTS WENT FROM T11 TO L3. SURGERY WAS ABORTED IN ONE CASE DUE TO MASSIVE BLEEDING AND VENTILATING DIFFICULTIES. THERE WERE TWO PARTIAL AND FOUR TOTAL VERTEBRAL RESECTIONS. MEDIAN OPERATING DURATION AND ESTIMATED BLOOD LOSS WERE 405 MIN (RANGE, 360¿540) AND 2.1 L (RANGE, 1.2¿19), RESPECTIVELY. POSTOPERATIVE COMPLICATIONS CONSISTED OF 1 URINARY INFECTION; 1 TRANSIENT URINARY RETENTION; 1 POSTERIOR WOUND INFECTION; 1 PNEUMOTHORAX; 1 PERSISTENT PARTIAL MOTOR DEFICIT; 1 TRANSIENT CONFUSION; 1 PULMONARY EMBOLISM; 1 CSF LEAK; 1 SUBDURAL HEMATOMA; 1 RETROPERITONEAL LYMPHOCELE. ALL MARGINS WERE UNCONTAMINATED. ALL PATIENTS WERE ALIVE AND AMBULATORY AT LAST FOLLOW-UP. CONCLUSION: EARLY RESULTS SUGGEST EN BLOC RESECTION ASSISTED BY RETROPERITONEAL VIDEOSCOPY IN TUMORS FROM T11 TO L3/4 DISK SPACE IS FEASIBLE, LESS INVASIVE AND SAFE. CAREFUL SURGICAL PLANNING AND EXPERIENCE IN ENDOSCOPIC VASCULAR SURGERY ARE MANDATORY. REPORTED EVENT(S): SURGERY FOR PATIENT 6 (MALE, 67 YEARS OLD) WAS ABORTED DURING THE RESECTION OWING TO AN UNCONTROLLABLE EPIDURAL VEINS BLEEDING AND DIFFICULTIES IN VENTILATING THE PATIENT. THIS OBESE PATIENT WAS UNDER ASPIRIN WHICH WAS NOT DISCONTINUED FOR THE SURGERY. IN ADDITION, HE HAD A RETROAORTIC LEFT RENAL VEIN THAT RENDERED THE DISSECTION EXTREMELY COMPLEX. PATIENT WENT TO ICU AND WAS EXTUBATED AT DAY 1. TUMOR RESECTION WAS COMPLETED AFTER 5 DAYS OF ASPIRIN DISCONTINUATION THROUGH A LUMBOTOMY IN LATERAL POSITION WITH REOPENING OF THE POSTERIOR APPROACH. ULTIMATELY, SPECIMEN WAS REMOVED EN BLOC WITH UNCONTAMINATED MARGINS. INTRA-OPERATIVE COMPLICATIONS WERE NOTED TO BE HYPOVOLEMIC CHOC, MASSIVE TRANSFUSION (16 RBC UNITS), AND VENTILATING DIFFICULTIES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2000128 O-ARM IMAGING SYSTEM IMAGE-INTENSIFIED FLUOROSCOPIC X-RAY SYSTEM, M OXO MEDTRONIC NAVIGATION, INC. (BOXBOROUGH) UNK_OARM_SYS

Patients

Seq Age Sex Outcome Treatment
1 67 YR Male Required Intervention| H